Selventa Strengthens Intellectual Property for System Diagnostics (SysDx™) Approach to Personalized Medicine

Published: May 08, 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Selventa today announced that it has been granted United States patent (No. No 8,417,661) titled “Method for Quantifying Amplitude of a Response of a Biological Network.” This patent is core to Selventa’s SysDx™ approach to mining and comparing biological data for predicting a patient’s response or non-response to a drug.

Help employers find you! Check out all the jobs and post your resume.

Back to news